CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 1, 2000, Pages 74-81

  Tullberg, M ^a   Mansson J E ^a   Fredman, P ^a   Lekman, A ^a   Blennow, K ^a   Ekman, R ^a   Rosengren, L E ^a   Tisell, M ^a   Wikkelso, C ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Normal pressure hydrocephalus; Subcortical arteriosclerotic encephalopathy; Sulfatide

Indexed keywords

4 AMINOBUTYRIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPHOSPHOLIPID; HOMOVANILLIC ACID; NEUROFILAMENT PROTEIN; SULFATIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ARTICLE; BINSWANGER ENCEPHALOPATHY; CEREBROSPINAL FLUID LEVEL; DEMYELINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMETRY; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; REFERENCE VALUES; SULFOGLYCOSPHINGOLIPIDS;

EID: 0034083532     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.1.74     Document Type: Article

References (54)

1. Adams RD, Fisher CM, Hakim S, et al. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med 1965;273:117-26.
2. Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 1965;2:307-27.
3. Milhorat TH, Clark RG, Hammock MK, et al. Structural, ultrastructural, and permeability changes in the ependyma and surrounding brain favoring equilibration in progressive hydrocephalus. Arch Neurol 1970;22:397-407.
4. Milhorat TH. The third circulation revisited. J Neurosurg 1975;42:628-45.
5. Miyagami M, Shibuya T, Tsubokawa T. Subependymal CSF absorption in hydrocephalic oedema. In: Matsumoto S, and Tamaki N, eds. Hydrocephalus, pathagenesis and treatment. Tokyo: Springer Verlag, 1981:181-94.
6. Deo Narine V, Gomez DG, Vullo T, et al. Direct in vivo observation of transventricular absorption in the hydrocephalic dog using magnetic resonance imaging. Invest Radiol 1994;29:287-93.
7. Weller RO, Wisniewski H, Shulman K. Experimental hydrocephalus in young dogs. J Neuropathol Exp Neurol 1971;30:613-26.
8. Akai K, Uchigasaki S, Tanaka U, et al. Normal pressure hydrocephalus. Neuropathological study. Acta Pathologica Japonicum 1987;37:97-110.
9. Godersky JC, Graff Radford NR, Yuh WT. Magnetic resonance imaging of patients with normal pressure hydrocephalus. Adv Neurol 1990;52:554.
10. Bradley Jr WG, Whittemore AR, Watanabe AS, et al. Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus [see comments]. Am J Neuroradiol 1991;12:31-9.
11. Davis PC, Mirra SS, Alazraki N. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. Am J Roentgenol 1994;162:1267-78.
12. Krauss JK, Droste DW, Vach W, et al. Cerebrospinal fluid shunting in idiopathic normal-pressure hydrocephalus of the elderly: effect of periventricular and deep white matter lesions. Neurosurgery 1996;39:292-9.
13. Babikian V, Ropper AH. Binswanger's disease: a review. Stroke 1987;18:2-12.
14. Bennett DA, Wilson RS, Gilley DW, et al. Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry 1990;53:961-5.
15. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 1995;26:1293-301.
16. Akiguchi I, Tomimoto H, Suenaga T, et al. Alterations in glia and axons in the brains of Binswanger's disease patients. Stroke 1997;28:1423-9.
17. Zhang WW, Olsson Y. The angiopathy of subcortical arteriosclerotic encephalopathy (Binswanger's disease): immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. Acta Neuropathol (Berl) 1997;93:219-24.
18. Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 1994;5:145-7.
19. Bracco L, Campani D, Baratti E, et al. Relation between MRI features and dementia in cerebrovascular disease patients with leukoaraiosis: a longitudinal study. J Neurol Sci 1993;120:131-6.
20. Graff Radford NR, Godersky JC. Idiopathic normal pressure hydrocephalus and systemic hypertension. Neurology 1987;37:868-71.
21. Koto A, Rosenburg G, Zingesser LH, et al. Syndrome of normal pressure hydrocephalus: possible relation to hypertensive and arteriosclerotic vasculopathy. J Neurol Neurosurg Psychiatry 1977;40:73-9.
22. Tullberg M, Rosengren L, Blomsterwall E, et al. CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology 1998;50:1122-7.
23. Sutton LN, Wood JH, Brooks BR, et al. Cerebrospinal fluid myelin basic protein in hydrocephalus. J Neurosurg 1983;59:467-70.
24. Skoog I, Wallin A, Fredman P, et al. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology 1998;50:966-71.
25. Wikkelso C, Blomstrand C. Cerebrospinal fluid proteins and cells in normal-pressure hydrocephalus. J Neurol 1982; 228:171-80.
26. Larsson A, Moonen M, Bergh AC, et al. Predictive value of quantitative cisternography in normal pressure hydrocephalus. Acta Neurol Scand 1990;81:327-32.
27. Wikkelso C, Andersson H, Blomstrand C, et al. Normal pressure hydrocephalus. Predictive value of the cerebrospinal fluid tap-test. Acta Neurol Scand 1986;73:566-73.
28. Larsson A, Bergh AC, Bilting M, et al. Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects. Eur J Nucl Med 1994;21:118-23.
29. Graff Radford NR, Rezai K, Godersky JC, et al. Regional cerebral blood flow in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 1987;50:1589-96.
30. Larsson A, Wikkelso C, Bilting M, et al. Clinical parameters in 74 consecutive patients shunt operated for normal pressure hydrocephalus. Acta Neurol Scand 1991;84:475-82.
31. Blomsterwall E, Bilting M, Stephensen H, et al. Gait abnormality is not the only motor disturbance in normal pressure hydrocephalus. Scand J Rehabil Med 1995;27:205-9.
32. Lindqvist G, Andersson H, Bilting M, et al. Normal pressure hydrocephalus: psychiatric findings before and after shunt operation classified in a new diagnostic system for organic psychiatry. Acta Psychiatr Scand Suppl 1993;373:18-32.
33. Blennow K, Wallin A, Gottfries CG, et al. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. J Neurol Transm Park Dis Dement Sect 1993;5:5-15.
34. Davidsson P, Fredman P, Mansson JE, et al. Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique. Clin Chim Acta 1991;197:105-15.
35. Fredman P, Wallin A, Blennow K, et al. Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Acta Neurol Scand 1992;85:103-6.
36. Widerlov E, Lindstrom LH, Wahlestedt C, et al. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res 1988;22:69-79.
37. Wikkelso C, Ekman R, Westergren I, et al. Neuropeptides in cerebrospinal fluid in normal-pressure hydrocephalus and dementia. Eur Neurol 1991;31:88-93.
38. Blennow K, Wallin A, Agren H, et al. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 1995;26:231-45.
39. Lekman A, Fredman P. A new procedure for determining ganglioside GD3 a potential glial cell activation marker in cerebrospinal fluid. Neurochem Int 1998;33:103-8.
40. Goldsmith RF, Earl JW, Cunningham AM. Determination of delta-aminobutyric acid and other amino acids in cerebrospinal fluid of pediatric patients by reversed-phase liquid chromatography. Clin Chem 1987;33:1736-10.
41. Rosengren LE, Karlsson JE, Karlsson JO, et al. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 1996;67:2013-18.
42. Rosengren LE, Wikkelso C, Hagberg L. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J Neurosci Meth 1994;51:197-204.
43. Mantel N. Chi-square test with one degree of freedom. Extension of the Mantel-Haenzel procedure. Journal of the American Statistical Association 1963;59:690-700.
44. Bradley JV. Distribution-free statistical test. London: Prentice-Hall, 1968.
45. Rosengren B, Fredman P, Månsson J-E, et al. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain. J Neurochem 1989;52:1035-11.
46. Svennerholm L, Boström K, Fredman P, et al. Membrane lipids of human peripheral nerve and spinal cord. Biochim Biophys Acta 1992;1128:1-7.
47. Malm G, Ringden O, Winiarski J, et al. Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplantation 1996;17:1003-8.
48. Pantoni L, Garcia JH, Brown GG. Vascular pathology in three cases of progressive cognitive deterioration. J Neurol Sci 1996;135:131-9.
49. Bech RA, Juhler M, Waldemar G, et al. Frontal brain and leptomeningeal biopsy specimens correlated with cerebrospinal fluid outflow resistance and B-wave activity in patients suspected of normal-pressure hydrocephalus. Neurosurgery 1997;40:497-502.
50. Albrechtsen M, Sorensen PS, Gjerris F, et al. High cerebrospinal fluid concentration of glial fibrillary acidic protein (GFAP) in patients with normal pressure hydrocephalus. J Neurol Sci 1985;70:269-74.
51. Rosengren L E, Karlsson J E, Sjogren M, et al. Neurofilament protein levels in CSF are increased in dementia. Neurology 1999;23;52:1090-3.
52. Otto M, Wiltfang J, Tumani H, et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997;225:210-2.
53. Malm J, Kristensen B, Ekstedt J, et al. CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters. J Neurol Neurosurg Psychiatry 1991;54:252-9.
54. Wikkelso C, Fahrenkrug J, Blomstrand C, et al. Dementia of different etiologies: vasoactive intestinal polypeptide in CSF. Neurology 1985;35:592-5.